Skip to main page content

• HOME
• Current Issue
• Archive
• Alerts
• About ASM
• Contact us
• Tech Support
• Journals.ASM.org

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Vela, A. I. Articles by Fernández-Garayzábal, J. F. Search for Related Content PubMed PubMed Citation Articles by Vela, A. I. Articles by Fernández-Garayzábal, J. F.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, June 2006, p. 2242-2243, Vol. 44, No. 6
0095-1137/06/$08.00+0     doi:10.1128/JCM.02473-05
Copyright © 2006, American Society for Microbiology. All Rights Reserved.

Isolation of Corynebacterium xerosis from Animal Clinical Specimens

A. I. Vela,¹ E. Gracía,² A. Fernández,² L. Domínguez,¹ and J. F. Fernández-Garayzábal^1*

Departamento de Sanidad Animal, Facultad de Veterinaria, Universidad Complutense, 28040 Madrid, Spain,¹ Laboratorio Exopol, Polígono del Río Gallego D/8, 50840 San Mateo, Zaragoza, Spain²

Received 30 November 2005/ Returned for modification 13 February 2006/ Accepted 26 March 2006

Top Abstract Text References

 
This article describes the first identification of Corynebacterium xerosis from animal clinical specimens, which was confirmed by microbiological and molecular genetic (16S rRNA gene sequencing) methods.

Top Abstract Text References

 
Corynebacterium xerosis is considered a commensal microorganism of human skin and mucous membranes. There are a limited number of reports associating C. xerosis with different human infections (1, 6), but it has been demonstrated that most of the C. xerosis isolates identified in the routine clinical laboratory represent Corynebacterium amycolatum strains (5, 6). Therefore, true human clinical isolates of C. xerosis are extremely rare (8), and there are no reports of its isolation from animals. We report the isolation and biochemical and genetic identification of eight strains of C. xerosis from different animal clinical specimens.

The eight isolates identified in this study were recovered from different clinical specimens routinely submitted for microbiological diagnosis to the Exopol laboratory in Zaragoza, Spain. Clinical specimens were collected under aseptic conditions and cultured aerobically on Columbia sheep blood agar (Oxoid España, Madrid, Spain) for 24 to 48 h at 37°C. For all clinical specimens, C. xerosis was recovered in moderate to high numbers in pure culture or as the predominant isolate from normally sterile body locations. Details of the clinical isolates are given in Table 1. Although only eight isolates were biochemically and genetically identified, coryneform bacteria similar to isolates St33874, St34960, St38671, and St49327 (similar colony morphology on sheep blood agar plates and similar Gram stain morphology) were also recovered from other organs from the same animal or different animals in the same disease episode. Thus, coryneform bacteria similar to isolate St33874 were also recovered in pure culture from the liver, spleen, and kidney of the same animal and from the liver of a second pig. A coryneform bacterium similar to isolate St34960 was also recovered in pure culture from the liver of the same animal. A coryneform bacterium similar to St38671 was also isolated from the joint of another pig; in this case, Mycoplasma hyosinoviae was also detected by immunocytochemistry. Coryneform bacteria similar to isolate St49327 were also recovered in pure culture from the liver and kidney of the same animal.

View this table: [in this window] [in a new window]

TABLE 1. Details of clinical isolates included in this study

Preliminary identification of the clinical isolates as Corynebacterium spp. was performed following standard procedures (4, 10). Further biochemical identification was achieved by using the commercial API Coryne (version 2.0) system (bioMérieux España S.A., Madrid, Spain) according to the manufacturer's instructions. The lipophilic requirement was determined by growing the isolates on brain heart infusion agar supplemented with 1% Tween 80 and comparing them to isolates grown on brain heart infusion agar lacking lipid supplementation. Antimicrobial susceptibility was tested by the disk diffusion method on Mueller-Hinton agar (bioMérieux España S.A.) according to the protocol of the Clinical and Laboratory Standards Institute (CLSI; formerly NCCLS) (9). The 16S rRNA genes of the eight isolates were amplified by PCR and further sequenced to determine their genotypic identities (11). The determined sequences consisted of about 1,400 nucleotides and were compared with the sequences of other gram-positive and catalase-positive species available in the GenBank database by using the FASTA program (http://www.ebi.ac.uk/fasta33).

The eight isolates grew on sheep blood agar, forming small (1 to 2 mm in diameter after 48 h of incubation), dry, and rough colonies with a yellowish pigment. They consisted of gram-positive, nonmotile, non-spore-forming, catalase-positive, rod-shaped organisms that were tentatively identified as Corynebacterium spp. The isolates were nonhemolytic and nonlipophilic and gave two numerical profiles with the API Coryne system, i.e., 2110325 (St36404) and 3110325 (St33874, St34960, St36130, St38671, St49845, St49327, and St47126), that correspond to a doubtful discrimination between Corynebacterium striatum and C. amycolatum. The API Coryne database does not include C. xerosis, which can create misidentification when using this commercial identification system (5). The clinical isolates were able to produce acid from maltose and exhibited strong -glucosidase activity, which are among the few biochemical test results that can differentiate C. xerosis from C. striatum and C. amycolatum (5, 6). Clinical isolates were susceptible to penicillin, ampicillin, amoxicillin-clavulanic acid, doxycycline, ceftiofur, cephalexin, gentamicin, oxytetracycline, and enrofloxacin, which also agrees with previous data about the antimicrobial susceptibility of C. xerosis, whereas strains of C. amycolatum are typically resistant to most of these antibiotics (5).

Sequencing of the 16S rRNA gene is a very useful tool for the identification of unusual clinical isolates or those which cannot be identified easily by conventional phenotypic methods (2, 7, 12). The 16S rRNA gene analysis revealed that all isolates were genotypically identical, displaying 100% and 99.8% sequence similarity with C. xerosis (accession numbers AF145257 and X84446, respectively). The overall phenotypic characterization results for the clinical isolates were consistent with those described for this species (5, 6), and they support the genetic identification of the clinical isolates as C. xerosis. Strain St36130 has been deposited in the Spanish Type Culture Collection as strain CECT 7156.

Although only a few species of Corynebacterium are traditionally considered well-recognized animal pathogens (10), the genus Corynebacterium has been subjected during the last decade to a substantial taxonomic revision with the description of a plethora of new species from human and animal sources (4, 6), some of which have a pathogenic role (3). This report represents the first identification of C. xerosis from animal clinical specimens, which was confirmed by molecular genetic methods. Although most isolates of C. xerosis were isolated in pure culture from normally sterile organs (Table 1), which may be indicative of clinical significance, in a few cases it was isolated from other organs of the same animal or different animals in the same disease episode, together with other veterinary pathogens, such as Streptococcus suis, Mycoplasma hyopneumoniae, or M. hyosinoviae, which makes it difficult to draw conclusions about the possible pathogenic character of C. xerosis for animals. Nevertheless, the report of the identification of C. xerosis from clinical samples of animals may be useful for veterinary clinical microbiologists to improve the knowledge of its distribution and its possible association with disease in animals.

Nucleotide sequence accession number. The 16S rRNA gene nucleotide sequence for strain St36130 has been deposited in the GenBank/EMBL data library under accession number AM233487.

 
* Corresponding author. Mailing address: Departamento de Sanidad Animal, Facultad de Veterinaria, Universidad Complutense, 28040 Madrid, Spain. Phone: 34-913-943-716. Fax: 34-913-943-908. E-mail: garayzab{at}vet.ucm.es.

Top Abstract Text References

 

1
1. Coyle, M. B., and B. A. Lipsky. 1990. Coryneform bacteria in infectious diseases: clinical and laboratory aspects. Clin. Microbiol. Rev. 3:227-246.[Abstract/Free Full Text]
2
2. Drancourt, M., and D. Raoult. 2005. Sequence-based identification of new bacteria: a proposition for creation of an orphan bacterium repository. J. Clin. Microbiol. 43:4311-4315.[Free Full Text]
3
3. Fernández-Garayzábal, J. F., M. D. Collins, R. A. Hutson, E. Fernández, R. Monasterio, R. Marco, and L. Domínguez. 1997. Corynebacterium mastitidis sp. nov., isolated from milk of sheep with subclinical mastitis. Int. J. Syst. Bacteriol. 47:1082-1085.[Abstract/Free Full Text]
4
4. Funke, G., and K. A. Bernard. 2003. Coryneform gram-positive rods, p. 472-501. In P. R. Murray, E. J. Baron, J. H. Jorgensen, M. A. Pfaller, and R. H. Yolken (ed.), Manual of clinical microbiology, 8th ed. ASM Press, Washington, D.C.
5
5. Funke, G., P. A. Lawson, K. A. Bernard, and M. D. Collins. 1996. Most Corynebacterium xerosis strains identified in the routine clinical laboratory correspond to Corynebacterium amycolatum. J. Clin. Microbiol. 34:1124-1128.[Abstract]
6
6. Funke, G., A. von Gravenitz, J. A. Clarridge III, and K. A. Bernard. 1997. Clinical microbiology of coryneform bacteria. Clin. Microbiol. Rev. 10:125-159.[Abstract]
7
7. Gibello, A., A. I. Mata, M. M. Blanco, A. Casamayor, L. Domínguez, and J. F. Fernández-Garayzábal. 2005. First identification of Streptococcus phocae isolated from Atlantic salmon (Salmo salar). J. Clin. Microbiol. 43:526-527.[Free Full Text]
8
8. Lagrou, K., J. Verhaegen, M. Manssens, G. Wauters, and L. Verbist. 1998. Prospective study of catalase-positive coryneform organisms in clinical specimens: identification, clinical relevance and antibiotic susceptibility. Diagn. Microbiol. Infect. Dis. 30:7-15.[CrossRef][Medline]
9
9. National Committee for Clinical Laboratory Standards. 2002. Performance standards for antimicrobial disk and dilution susceptibility test for bacteria isolated from animals. Approved standard M31-A2, 2nd ed. National Committee for Clinical Laboratory Standards, Wayne, Pa.
10
10. Quinn, P., M. E. Carter, B. Markey, and G. R. Carter. 1999. Corynebacterium species and Rhodococcus equi, p. 137-143. In P. J. Quinn, M. E. Carter, B. Markey, and G. R. Carter (ed.), Clinical veterinary microbiology. Mosby, Edinburgh, Scotland.
11
11. Vela, A. I., A. Mateos, M. D. Collins, V. Briones, R. Hutson, L. Domínguez, and J. F. Fernández-Garayzábal. 2003. Corynebacterium suicordis sp. nov., from pigs. Int. J. Syst. Evol. Microbiol. 53:2027-2031.[Abstract/Free Full Text]
12
12. Vela, A. I., C. Porrero, J. Goyache, A. Nieto, B. Sánchez, V. Briones, M. A. Moreno, L. Domínguez, and J. F. Fernández-Garayzábal. 2003. Weissella confusa infection in a primate (Cercopithecus mona). Emerg. Infect. Dis. 9:1307-1309.[Medline]

---

Journal of Clinical Microbiology, June 2006, p. 2242-2243, Vol. 44, No. 6
0095-1137/06/$08.00+0     doi:10.1128/JCM.02473-05
Copyright © 2006, American Society for Microbiology. All Rights Reserved.

This article has been cited by other articles:

• Lee, H. J., Cho, S.-L., Jung, M. Y., Van Nguyen, T. H., Jung, Y.-C., Park, H. K., Le, V. P., Kim, W. (2009). Corynebacterium doosanense sp. nov., isolated from activated sludge. Int. J. Syst. Evol. Microbiol. 59: 2734-2737 [Abstract] [Full Text]  
• Renaud, F. N. R., Coustumier, A. L., Wilhem, N., Aubel, D., Riegel, P., Bollet, C., Freney, J. (2007). Corynebacterium hansenii sp. nov., an {alpha}-glucosidase-negative bacterium related to Corynebacterium xerosis. Int. J. Syst. Evol. Microbiol. 57: 1113-1116 [Abstract] [Full Text]  

This Article Abstract Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Vela, A. I. Articles by Fernández-Garayzábal, J. F. Search for Related Content PubMed PubMed Citation Articles by Vela, A. I. Articles by Fernández-Garayzábal, J. F.